Trans rights in the UK: from the Gender Recognition Act to the Cass Review

The United Kingdom was, for decades, a European benchmark on LGBT+ rights. It was the first country to introduce the Gender Recognition Act in 2004, enabling legal recognition of gender identity. Twenty years later, that same country has banned puberty blockers, redefined the legal meaning of the word “woman,” and triggered a domino effect of exclusions from historic organizations. Here is what is happening — and the data missing from the debate.

The Cass Review: the report that changed everything

On April 10, 2024, Dr. Hilary Cass — former president of the Royal College of Paediatrics and Child Health — published the final report of the independent review commissioned by NHS England in 2020 [1]. The objective was to evaluate gender identity services for children and adolescents. The result was a 388-page document destined to reshape British healthcare policy.

What the report says

The Cass Review examined 50 studies on puberty blockers and 53 on hormones, concluding that the available scientific evidence is “remarkably weak” [1]. The main recommendations: puberty blockers should be administered to minors only within controlled clinical trials, not as routine treatment [1]. NHS England accepted all 32 recommendations of the report, initiating a radical reorganization of services [2].

The Royal College of Psychiatrists expressed support for the conclusions. The National Institute for Health and Care Research (NIHR) announced the “Pathways Trial,” a clinical study coordinated by King’s College London involving 226 minors under 16 with a diagnosis of gender incongruence, with a planned start in January 2026.

The criticisms: what does not add up

Here is the point often omitted from the debate: the Cass Review was not received without objections from the international scientific community.

In July 2024, the Yale Integrity Project published a detailed critical analysis (An Evidence-Based Critique of the Cass Review), raising significant methodological issues: the review had allegedly excluded evidence in favor of affirmative care and applied inconsistent evaluation standards [3].

In 2025, a study published in BMC Medical Research Methodology (Noone et al.) applied the ROBIS tool — the gold standard for assessing risk of bias in systematic reviews — to the seven reviews commissioned by the Cass Review. The result: high risk of bias in all seven [4]. The identified issues include unexplained deviations from protocols, ambiguous eligibility criteria, inadequate identification of studies, and failure to integrate limitations into the conclusions [4].

The key takeaway: the Cass Review has not been “debunked.” But its scientific basis is seriously and well-documented contested, in peer-reviewed journals. This does not mean its conclusions are wrong — it means the scientific debate is still open, and anyone presenting the report as a definitive verdict is oversimplifying.

The scientific societies of Germany, Austria, and Switzerland published new transgender healthcare guidelines in 2025 that explicitly distance themselves from the Cass Review’s methodology.

Bell v Tavistock: the court case that preceded everything

Before the Cass Review, the British debate had already erupted with a landmark court case.

Keira Bell was referred to the Gender Identity Development Service (GIDS) at the Tavistock and Portman NHS Foundation Trust at age 15. At 16 she was prescribed puberty blockers, at 17 testosterone, and at 20 she underwent a bilateral mastectomy. Around age 22 she detransitioned, initiating legal action against the service that had treated her [5].

The chain of rulings

December 2020 — High Court: the ruling established that minors under 16 are unlikely to be able to provide adequate informed consent for puberty blockers [5]. The decision had an immediate effect: the Tavistock suspended new referrals.
September 2021 — Court of Appeal: the verdict was overturned [5]. The judges ruled that the High Court had overstepped its role: the assessment of consent capacity falls to doctors, not courts. The decision reaffirmed the principle of Gillick competence — the legal criterion that, since 1985, recognizes minors’ ability to give informed consent if they demonstrate sufficient understanding.
April 2022 — Supreme Court: refused permission to appeal, stating that the case “does not raise an arguable point of law” [5].

The implication: from a legal standpoint, British courts established that minors can consent to puberty blockers. But healthcare policy took a completely opposite direction.

The puberty blockers ban: the timeline

The sequence of events is rapid and has few precedents in a democratic country.

March 2024: NHS England ceases the routine prescription of puberty blockers for gender dysphoria in minors, based on evidence produced by NICE and the Cass Review [1][2].
June 2024: the government adopts emergency legislation — the Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024 — which also bans the private prescription of blockers for gender incongruence to under-18s [6].
January 1, 2025: the ban becomes permanent [6]. The Commission on Human Medicines (CHM) judged that there is “an unacceptable safety risk” in continued prescribing. The ban will be reviewed in 2027.

What remains possible: puberty blockers continue to be prescribed for other medical conditions, such as precocious puberty. Those already in treatment can continue. But for new patients with gender dysphoria, the only route is participation in the clinical trial.

The paradox: the same drug, with the same active ingredient, is considered safe for one diagnosis and unsafe for another. The difference is not pharmacological — it is political.

For Women Scotland: when the Supreme Court redefines “woman”

On April 16, 2025, the UK Supreme Court issued a unanimous ruling in the case For Women Scotland Ltd v The Scottish Ministers [2025] UKSC 16 destined to rewrite the architecture of rights [7].

What the ruling established

The Court ruled that the term “sex” in the Equality Act 2010 refers to biological sex, not gender identity [7]. A “woman,” for the purposes of the law, is a person born female. Consequently, a Gender Recognition Certificate (GRC) — the document that since 2004 has allowed trans people to obtain legal recognition of their gender — does not change a person’s sex for the purposes of anti-discrimination law [7].

In practical terms: trans women can be excluded from spaces and services reserved for women, if the exclusion is “proportionate” and justified.

International reactions: a divided world

The ruling produced a sharp split, even within international institutions.

Human Rights Watch called the ruling “severely regressive” [8]. Yasmine Ahmed, UK director, stated that the country, once a global leader on LGBT rights, “has stained its reputation with a ruling that offends the dignity of trans and intersex people” [8].

The Lancet published an editorial warning about the medical implications of the ruling, highlighting the risks to access to care and the mental health of trans people [9].

At the United Nations, an unprecedented split occurred among its own experts:

The Special Rapporteur on violence against women, Reem Alsalem, welcomed the ruling, arguing that spaces reserved exclusively for biological women “are vital for the protection of the rights of women and girls” [11].
A group of independent human rights experts warned instead that the ruling “risks entrenching legal uncertainty and undermining the rights of transgender people in all aspects of life” [10].

The Court nonetheless clarified that trans people retain the protections provided by the Equality Act as holders of the protected characteristic of “gender reassignment” [7]. The ruling does not eliminate these protections — but it radically changes the scope of their application.

The blocked Scottish law: a constitutional precedent

On December 22, 2022, the Scottish Parliament passed the Gender Recognition Reform (Scotland) Bill with 86 votes in favor and 39 against [12]. The law would have allowed obtaining a GRC from age 16, without the need for a medical diagnosis, with a reduced waiting period of three months (six for 16-17 year olds) [12].

On January 17, 2023, the Westminster government invoked Section 35 of the Scotland Act 1998 to prevent the bill from receiving Royal Assent [13]. It was the first time in the history of Scottish devolution that Westminster blocked a law passed by the Edinburgh Parliament [13].

The Secretary of State for Scotland, Alister Jack, justified the decision by arguing that the law would have “adverse effects” on the application of the Equality Act 2010, a matter reserved to Westminster [13].

The Scottish government challenged the decision before the Court of Session. On December 8, 2023, the court dismissed the appeal, confirming the legitimacy of Westminster’s veto [12].

The constitutional implication: the block established that, in matters of civil rights, the central government can override the democratic will of the Scottish Parliament when it considers that a law interferes with reserved legislation [13]. For supporters of the law, it was an attack on Scotland’s legislative autonomy. For critics, a correct exercise of constitutional prerogatives.

The domino effect: who closed their doors after the ruling

The Supreme Court ruling of April 2025 did not stay in the courtrooms. In the months that followed, historic British organizations modified their admission policies.

Girlguiding (the British Girl Guides): on December 2, 2025, announced that trans girls and young women can no longer enroll. The organization stated it was acting “with a heavy heart” to comply with the Supreme Court ruling. Adult roles remain open to all.
Women’s Institute (the largest women’s organization in the UK): announced that, from April 2026, membership will be reserved for biological women only [15]. The CEO spoke of a decision taken with “the utmost regret and sadness.” Several local groups announced they would close in protest [15].
Labour Party: excluded trans women from the main sessions of the Labour Women’s Conference, allowing them to participate only in fringe events, which are open to everyone regardless of gender.

The fact missing from the debate: none of these organizations was required by the ruling to modify their policies. The Court established that exclusion is lawful, not that it is mandatory [7]. The choice to exclude was, in every case, an autonomous decision by each organization.

The waiting lists: the numbers nobody wants to read

While the political and judicial debate dominates the front pages, there is a silent crisis affecting tens of thousands of people.

As of March 2025, over 48,000 people were waiting for a first appointment at an NHS gender identity clinic — an increase of 12.5% compared to the previous year [14]. The standard set by the NHS Constitution is a maximum wait of 18 weeks. The reality is something else entirely.

Actual waiting times

The data collected through journalistic investigations and from the clinics’ own websites reveal a situation that defies comprehension [14]:

Nottingham: approximately 3 years of waiting — the most “optimistic” figure in the British landscape.
Sheffield: 280 weeks (over 5 years). As of November 2025, the clinic was scheduling appointments for people referred in October 2020.
Northern Region (Walkergate Park): the person at the top of the list in November 2025 had waited 81 months — nearly 7 years.
Belfast: estimated wait of approximately 41 years.
Glasgow: estimated wait of approximately 224 years [14].

Let that sink in: 224 years. That is not a typographical error. At the current rate of clearing the lists and the flow of new referrals, a person placed on the list in Glasgow today would have to wait until 2249. For every person who receives a first appointment, four new people are added to the list [14].

The implication: regardless of one’s position on the Cass Review or the Supreme Court ruling, these numbers describe a healthcare system that has ceased to function for trans people. This is not a political opinion: it is a fact. The waiting times in Belfast and Glasgow amount, in effect, to a denial of service.

The overall picture: what all this means

Between 2020 and 2025, the United Kingdom made a series of moves that, taken individually, may appear as prudent responses to complex issues. Viewed together, they trace a clear trajectory.

Here is the sequence:

An independent review concludes that the evidence for treatment of gender dysphoria in minors is weak (2024) [1].
The national health service ceases routine prescription of puberty blockers (March 2024) [2].
Private prescribing is banned by law (June 2024) [6].
The ban is made permanent (January 2025) [6].
The Supreme Court rules that “sex” means biological sex (April 2025) [7].
Historic organizations begin excluding trans women (late 2025) [15].
Waiting lists for care make access to NHS services virtually impossible (ongoing) [14].

Each step has its own internal logic. But the overall result is that a trans person in the United Kingdom, in 2026, finds themselves in a significantly more precarious position compared to five years ago — in terms of healthcare, legal standing, and social inclusion.

What remains to be understood

The debate is far from over. Several elements remain unresolved:

The results of the Pathways Trial on puberty blockers, expected no earlier than 2028-2029, may provide evidence that is currently lacking. But in the meantime, a generation of adolescents is going through puberty without the possibility of accessing treatment.
The European Court of Human Rights could be called upon to rule on the compatibility of the British measures with the European Convention. The ECHR has already established, in the case of A.P., Garcon and Nicot v. France (2017), that making gender recognition conditional on sterilization violates Article 8. It is unclear whether the For Women Scotland ruling will be challenged at the European level.
The Labour government of Keir Starmer, in power since July 2024, has shown no intention of reversing course from the policies of the previous Conservative government. On the contrary: the puberty blockers ban was made permanent under his government [6].

This article presents the facts as they are documented. The sources are linked in full. The reader has all the tools to form an informed opinion — which is exactly what they are entitled to.